Overview

Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients

Status:
Recruiting

Trial end date:
2021-12-30

Target enrollment:

Participant gender:

Summary

This study will examine the utility of chitosan for reduction of blood or tissue levels of AGEs in patients with prostate cancer who are clinically stable on androgen-deprivation therapy.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Medical University of South Carolina

Treatments:

Chitosan